Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer (Q72776953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

main subject

phase II clinical trial

1 reference

1 reference

2

C Erlichman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

S Fine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

L Kaizer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

D Warr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

T Gadalla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

205-209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00666065

29 October 2019

exact match

0 references

cites work

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

1 reference

12 December 2020

Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium

1 reference

12 December 2020

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

12 December 2020

Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancer

1 reference

12 December 2020

The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug

1 reference

12 December 2020

5-Fluorouracil with leucovorin in breast cancer

1 reference

12 December 2020

Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil

1 reference

12 December 2020

Allopurinol mouthwash for prevention of fluorouracil-induced stomatitis

1 reference

12 December 2020

5-Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: an update

1 reference

12 December 2020

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

1 reference

12 December 2020

Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: preliminary results

1 reference

12 December 2020

Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil

1 reference

12 December 2020

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1 reference

12 December 2020

A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group

1 reference

12 December 2020

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis

1 reference

12 December 2020

5-Fluorouracil by Protracted Venous Infusion: A Review of Recent Clinical Studies

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

1 reference

12 December 2020

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00666065

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949219%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference